New Drug Cuts Rare Swelling Attacks by 96% in Trial

A groundbreaking medication reduced severe swelling attacks by up to 96% in patients with a rare genetic disorder, offering hope with just two doses per year.

The treatment could transform life for thousands living with unpredictable, painful episodes.